Status:
COMPLETED
China Survey of Peptic Ulcer Bleeding
Lead Sponsor:
AstraZeneca
Conditions:
Peptic Ulcer Hemorrhage
Eligibility:
All Genders
18+ years
Brief Summary
This will be a multicenter prospective observational study carried out in China. The investigators will collect data in a pre-specified Case Report Form. Main data from each patient will include demog...
Eligibility Criteria
Inclusion
- Female and/or male aged 18 years and above
- Admitted to the hospital with an overt upper GI bleeding (hematemesis/coffee ground vomiting, melena, hematochezia and other clinical or laboratory evidence of acute blood loss from the upper GI tract)
- Endoscopy demonstrated peptic ulcer bleeding (Forrest I-III)
Exclusion
- If participating in any clinical trial, the subject cannot take part in this study.
Key Trial Info
Start Date :
November 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
July 1 2011
Estimated Enrollment :
1044 Patients enrolled
Trial Details
Trial ID
NCT01241266
Start Date
November 1 2010
End Date
July 1 2011
Last Update
December 30 2011
Active Locations (31)
Enter a location and click search to find clinical trials sorted by distance.
1
Research Site
Hefei, Anhui, China
2
Research Site
Beijing, Beijing Municipality, China
3
Research Site
Chongqing, Chongqing Municipality, China
4
Research Site
Fuzhou, Fujian, China